Advanced Cancer Therapies (ACT), the meeting formerly known as Regional Cancer Therapies, will be entering its 15th year with a name change that reflects the evolution of the meeting.
T. Clark Gamblin, MD, Program Chair for Advanced Cancer Therapies, said, “The original concept of the meeting was to focus on cancers treated with novel approaches due to limited treatment options. The program emphasized regional therapies, including HIPEC for carcinomatosis, regional limb infusions or perfusions for arm or leg sarcomas, melanomas and other diseases. It also focused on liver directed therapies in cases when cancers couldn’t be surgically removed, but treatable with other approaches.”
Dr. Gamblin explains, “The new name reflects an update in the content of the meeting, in that we’re looking beyond surgical therapy to understand that cancer care is multidisciplinary, and while it involves surgery, it also involves radiation and medical oncology, as well as novel surgical approaches for certain diseases. This is the meeting to learn and share clinical knowledge about regional therapies and cutting-edge technology for a variety of cancers.”
Presenters at ACT will include national and international leaders in the field. The meeting content will include debates on hot topics, research presentations, and discussion of challenging cases. In addition to a robust clinical presentation agenda, ACT will also conduct a new workshop on the infrastructure of building a HIPEC program. The workshop will include information on the different equipment needed, billing and coding. The Scientific Program Committee is also excited about the career development workshop. Dr. Gamblin said, “The career development portion of Advanced Cancer Therapies reflects the spirit of the meeting as a place to meet authorities in the field and forge relationships. It will also focus on success factors for publishing research that can help grow careers.”
Advanced Cancer Therapies will be held at the Rosen Shingle Creek Hotel in Orlando, Florida from February 15-17, 2020. Check the Advanced Cancer Therapies page for updates on when abstracts will be accepted, when registration opens, and other meeting details.